Latest Breaking News On - Monica stonehill - Page 6 : comparemela.com

EASL Congress 2023 rewind: What you may have missed; alcohol use, NASH data top agenda

EASL Congress 2023 rewind: What you may have missed; alcohol use, NASH data top agenda
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesMadhya pradeshNew delhiMarina serperElizabeth hamiltonRohit loombaStine johansenStephena harrisonMonica stonehillJavier abad guerraByjustin cooperPinnacle clinical researchUniversity of oxfordUniversity of pennsylvania readBiliary sciences

FDA gains steam in 2023: GI pipeline boasts numerous milestones, 2 crucial setbacks

FDA gains steam in 2023: GI pipeline boasts numerous milestones, 2 crucial setbacks
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Eli lillyByjustin cooperMonica stonehillAbbvie rinvoqUpadacitinib rinvoqSebela pharmaceuticalsIpsen albiero pharmaceuticalsFerring pharmaceuticalsIntercept pharmaceuticalsSeres therapeuticsDrug advisory committeePrescription drug user fee actIpsen biopharmaceuticalsAlbiero pharmaceuticalsOlympus medical

Encouraging ELATIVE data for elafibranor may spark race for primary biliary cholangitis

Encouraging ELATIVE data for elafibranor may spark race for primary biliary cholangitis
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Howard mayerMonica stonehillPascal prigentIpsen genfitDrug administrationEuropean medicines agency

FDA approves Suflave, Sebela s low-volume, lemon-lime flavored colonoscopy prep

The FDA has approved Suflave, an osmotic laxative consisting of polyethylene glycol, sodium sulfate, potassium chloride, magnesium sulfate and sodium chloride, for colonoscopy preparation in adults, according to the manufacturer. Sebela Pharmaceuticals noted that patient tolerance for bowel preparation remains a significant deterrent for those considering screening colonoscopy, with most patients

Monica stonehillAlan cookeDouglask rexSebela pharmaceuticalsDistinguished professor emeritusIndiana university school

Intercept pivots away from NASH following second FDA rejection for obeticholic acid

  The FDA issued a complete response letter to Intercept indicating it cannot approve the company’s new drug application for obeticholic acid as a treatment for pre-cirrhotic liver fibrosis due to nonalcoholic steatohepatitis.

Monica stonehillJerry dursoIntercept pharmaceuticalsDrug advisory committee